Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 05-2019 | 02-2019 | 11-2018 | 08-2018 | 05-2018 | |
| Sales | 682 | 666 | 674 | 0 | 617 |
| Cost of Goods | N/A | 55 | 35 | N/A | -86 |
| Gross Profit | 682 | 611 | 639 | N/A | 703 |
| Operating Expenses | 4,760 | 4,234 | 5,314 | 0 | 5,151 |
| Operating Income | -4,078 | -3,568 | -4,640 | N/A | -4,534 |
| Interest Expense | 14 | 19 | 8 | 0 | 29 |
| Other Income | 20 | 186 | 346 | 0 | 209 |
| Pre-tax Income | -4,072 | -3,401 | -4,302 | 0 | -4,354 |
| Income Tax | N/A | 300 | N/A | N/A | N/A |
| Net Income Continuous | -4,072 | -3,701 | -4,302 | N/A | -4,354 |
| Net Income | $-4,072 | $-3,701 | $-4,302 | $N/A | $-4,354 |
| EPS Basic Total Ops | -0.23 | -0.21 | -0.25 | N/A | -0.30 |
| EPS Basic Continuous Ops | -0.23 | -0.21 | -0.25 | N/A | -0.30 |
| EPS Diluted Total Ops | -0.23 | -0.21 | -0.25 | N/A | -0.30 |
| EPS Diluted Continuous Ops | -0.23 | -0.21 | -0.25 | N/A | -0.30 |
| EBITDA(a) | $-4,078 | $-3,564 | $-4,637 | $N/A | $-4,533 |